Yesterday, our Senior Economist Søren Brenøe delivered a keynote presentation on the economic impact of parallel imports of pharmaceuticals.

In a lively and engaging Q and A session, Søren expounded on everything from who benefits from parallel imports to how parallel imports can be seen as one element in the complex field of regulation, including intellectual property, faced by pharmaceutical companies.

If you missed the conference, you can find out about the key points that were discussed below.

Learn more about the conference

For forther information, please contact Senior Economist Søren Brenøe